Fidelity Investments’s Apollo Endosurgery, Inc. APEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-6,369
Closed -$63.2K 5693
2023
Q1
$63.2K Buy
6,369
+6,214
+4,009% +$61.6K ﹤0.01% 3352
2022
Q4
$1.54K Buy
+155
New +$1.16K ﹤0.01% 4570

Fidelity Investments's APEN Position: Q2 2023 in Review

Fidelity Investments sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 6,369 shares — an estimated $63.2K sold.

Fidelity Investments first reported a position in APEN in Q4 2022 and held it in 2 quarters. The position peaked at $63.2K in Q1 2023. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.

  • Fidelity Investments reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
  • Fidelity Investments sold 6,369 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $63.2K.
  • Fidelity Investments first reported a position in Apollo Endosurgery, Inc. in Q4 2022 and held it in 2 quarters.
  • Fidelity Investments's Apollo Endosurgery, Inc. position peaked at $63.2K in Q1 2023.
  • 0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.

Based on Fidelity Investments's 13F filing for Q2 2023, filed 11 Aug 2023.